Eighth Circuit Court Rules Unanimously for AAM in Generic Pricing Appeal
A Minnesota law was found by the district court and appeals court to unlawfully regulate prices in other states WASHINGTON, DC (June 12, 2025) –
A Minnesota law was found by the district court and appeals court to unlawfully regulate prices in other states WASHINGTON, DC (June 12, 2025) –
Settlements bring more affordable medicines to market over 5 years earlier WASHINGTON, DC (June 3, 2025) – The Association for Accessible Medicines and its Biosimilars
WASHINGTON (April 14, 2025) — The Association for Accessible Medicines today commented on an announcement by the Department of Commerce beginning a Section 232 investigation
Saves more than $800 million over 10 years; brings lower-cost medicines to patients sooner WASHINGTON (April 4, 2025) — The Association for Accessible Medicines today
WASHINGTON (April 3, 2025) — The Association for Accessible Medicines today congratulated Dr. Mehmet Oz, M.D., on Senate confirmation to lead the Centers for Medicare
WASHINGTON (April 1, 2025) — The Association for Accessible Medicines today commented on staffing cuts at the Food and Drug Administration, including key personnel responsible
WASHINGTON (March 27, 2025) — The Association for Accessible Medicines today congratulated Dr. Marty Makary, MD, MPH on his confirmation as Commissioner of the Food
Reps. Dunn and Mullin bill will cut red tape, bring lower-cost medicines to patients faster, and save more than $800 million over ten years WASHINGTON
A call to action to safeguard affordable generic and biosimilar medicines WASHINGTON (February 13, 2025) — The Association for Accessible Medicines today commented on the
WASHINGTON (February 4, 2025) — The Association for Accessible Medicines today published their 2025 advocacy priorities and regulatory and legislative reform recommendations: Protect and Defend
WASHINGTON (February 2, 2025) — The Association for Accessible Medicines today commented on the announcement that a 25% tariff will be imposed on Canada and
WASHINGTON (January 22, 2025) — The Board of Directors of the Association for Accessible Medicines has reelected as Chair for a second one-year term, Keren
